Table 1.
Clinical, laboratory, and imaging characteristics of the 31 patients hospitalized for screening of varicella-zoster virus (VZV) central nervous system (CNS) infection.
| Total (n = 31) | |
|---|---|
| Demographics and clinical characteristics | |
| Age, years | 30 (24.3–33.3) |
| Sex, male | 16 (51.6) |
| Comorbidity | 2 (6.5) |
| Recently contacted with chickenpox | 17 (54.8) |
| Time from chickenpox onset, days | 4.0 (3.0–5.0) |
| Time from neurological symptoms onset, days | 2 (1–4) |
| Headache | 29 (93.5) |
| Neuasia | 14 (45.2) |
| Vomitting | 6 (19.4) |
| Mental Change | 2 (6.5) |
| Difficulty urinating | 2 (6.5) |
| Nuchal rigidity | 4 (12.9) |
| Kernig's sign | 1 (3.2) |
| Brudzin ski's sign. | 0 (0) |
| Blood laboratory tests | |
| White blood cell count, × 109/L | 4.9 (3.9–7.0) |
| Lymphocyte count, × 109/L | 1.3 (1.1–2.9) |
| Lactate dehydrogenase, IU/L | 240.0 (202.5–289.5) |
| C-reactive protein, mg/L | 10.8 (2.7–20.9) |
| Cerebrospinal fluid analysis | |
| White blood cell count, × 106/L | 2.0 (1.0–5.0) |
| Proteins, mg/L | 261.4 (219.7–354.8) |
| Glucose, mmol/L | 3.2 (2.9–3.8) |
| Lactate dehydrogenase, IU/L | 17 (14–21) |
| Adenosine deaminase | 2 (0.1–3.6) |
| Negative bacterial culture | 31 (100) |
| Brain imaging | |
| Abnormal magnetic resonance imaging | 4 (12.9) |